| 000 | 01521 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250514031434.0 | ||
| 264 | 0 | _c20020614 | |
| 008 | 200206s 0 0 eng d | ||
| 022 | _a1073-2748 | ||
| 024 | 7 |
_a10.1177/107327480200900207 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aReff, Mitchell E | |
| 245 | 0 | 0 |
_aFuture of monoclonal antibodies in the treatment of hematologic malignancies. _h[electronic resource] |
| 260 |
_bCancer control : journal of the Moffitt Cancer Center _c |
||
| 300 |
_a152-66 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Bispecific _ximmunology |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _ximmunology |
| 650 | 0 | 4 | _aClinical Trials, Phase III as Topic |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aDrug Therapy |
| 650 | 0 | 4 | _aForecasting |
| 650 | 0 | 4 |
_aHematologic Neoplasms _ximmunology |
| 650 | 0 | 4 |
_aHost vs Graft Reaction _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmune System _xdrug effects |
| 650 | 0 | 4 | _aMulticenter Studies as Topic |
| 650 | 0 | 4 |
_aRadioimmunotherapy _xstandards |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aUnited States _xepidemiology |
| 650 | 0 | 4 | _aUnited States Food and Drug Administration |
| 700 | 1 | _aHariharan, Kandasamy | |
| 700 | 1 | _aBraslawsky, Gary | |
| 773 | 0 |
_tCancer control : journal of the Moffitt Cancer Center _gvol. 9 _gno. 2 _gp. 152-66 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/107327480200900207 _zAvailable from publisher's website |
| 999 |
_c11867242 _d11867242 |
||